Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_provenance.
- NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_provenance.
- NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_assertion evidence source_evidence_literature NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_provenance.
- NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_assertion SIO_000772 20597268 NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_provenance.
- NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_assertion wasDerivedFrom gad-20150221 NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_provenance.
- NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_assertion wasGeneratedBy ECO_0000203 NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_provenance.
- gad-20150221 importedOn "2015-02-21" NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_provenance.